{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T17:37:09Z","timestamp":1792431429151,"version":"4.5.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008871","name":"Yunnan Provincial Science and Technology Department","doi-asserted-by":"publisher","award":["202001AT070090"],"award-info":[{"award-number":["202001AT070090"]}],"id":[{"id":"10.13039\/501100008871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008871","name":"Yunnan Provincial Science and Technology Department","doi-asserted-by":"publisher","award":["202102AA310026"],"award-info":[{"award-number":["202102AA310026"]}],"id":[{"id":"10.13039\/501100008871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011450","name":"State Key Laboratory of Advanced Technologies for Comprehensive Utilization of Platinum Metals","doi-asserted-by":"publisher","award":["SKL-SPM-201802"],"award-info":[{"award-number":["SKL-SPM-201802"]}],"id":[{"id":"10.13039\/501100011450","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013152","name":"Shanghai Institute of Materia Medica, Chinese Academy of Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013152","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21661018"],"award-info":[{"award-number":["21661018"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Inorganic Biochemistry"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.jinorgbio.2023.112200","type":"journal-article","created":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T13:02:03Z","timestamp":1679490123000},"page":"112200","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Synthesis and biological evaluation of cholic acid-conjugated oxaliplatin as a new prodrug for liver cancer"],"prefix":"10.1016","volume":"243","author":[{"given":"Jing","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuguo","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaixuan","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiushuo","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuiping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anli","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemei","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanli","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingfei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinorgbio.2023.112200_bb0005","first-page":"7","article-title":"Cancer statistics","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.jinorgbio.2023.112200_bb0010","first-page":"115","article-title":"Cancer statistics in China","volume":"66","author":"Chen","year":"2016","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.jinorgbio.2023.112200_bb0015","doi-asserted-by":"crossref","first-page":"797","DOI":"10.4254\/wjh.v9.i18.797","article-title":"Systemic treatment of hepatocellular carcinoma: past, present and future","volume":"9","author":"Cidon","year":"2017","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.jinorgbio.2023.112200_bb0020","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1093\/annonc\/mdy308","article-title":"Hepatocellular carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"29","author":"Vogel","year":"2018","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jinorgbio.2023.112200_bb0025","first-page":"277","article-title":"Guidelines for diagnosis and treatment of primary liver cancer in China (2019 Edition)","volume":"36","author":"Bureau of Medical Administration, National Health Commission of the People's Republic of China","year":"2020","journal-title":"J. Clin. Hepatol."},{"key":"10.1016\/j.jinorgbio.2023.112200_bb0030","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1634\/theoncologist.2014-0190","article-title":"Efficacy and safety of the FOLFOX4 regimen versus doxorubicin in Chinese patients with advanced hepatocellular carcinoma: a subgroup analysis of the EACH study","volume":"19","author":"Qin","year":"2014","journal-title":"Oncologist."},{"key":"10.1016\/j.jinorgbio.2023.112200_bb0035","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrc2167","article-title":"The resurgence of platinum-based cancer chemotherapy","volume":"7","author":"Kelland","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jinorgbio.2023.112200_bb0040","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrd1287","article-title":"Oxaliplatin","volume":"3","author":"Graham","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jinorgbio.2023.112200_bb0045","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1200\/JCO.2012.44.5643","article-title":"Randomized, multicenter, open-label study of oxaliplatin plus fluorouracil\/leucovorin versus doxorubicin as palliative chemotherapy in patients with advanced hepatocellular carcinoma from Asia","volume":"31","author":"Qin","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jinorgbio.2023.112200_bb0050","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/cam4.1278","article-title":"Vorinostat enhances the anticancer effect of oxaliplatin on hepatocellular carcinoma cells","volume":"7","author":"Liao","year":"2018","journal-title":"Cancer Med."},{"key":"10.1016\/j.jinorgbio.2023.112200_bb0055","doi-asserted-by":"crossref","first-page":"717","DOI":"10.3389\/fonc.2019.00717","article-title":"High-affinity human anti-c-Met IgG conjugated to oxaliplatin as targeted chemotherapy for hepatocellular carcinoma","volume":"9","author":"Ma","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jinorgbio.2023.112200_bb0060","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ctrv.2006.09.006","article-title":"Molecular mechanisms of resistance and toxicity associated with platinating agents","volume":"33","author":"Rabik","year":"2007","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.jinorgbio.2023.112200_bb0065","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/j.1365-2362.1996.tb02383.x","article-title":"Bile acid transport systems as pharmaceutical targets","volume":"26","author":"Kramer","year":"1996","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.jinorgbio.2023.112200_bb0070","doi-asserted-by":"crossref","first-page":"18598","DOI":"10.1016\/S0021-9258(19)37003-6","article-title":"Liver-specific drug targeting by coupling to bile acids","volume":"267","author":"Kramer","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jinorgbio.2023.112200_bb0075","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1002\/hep.1840170528","article-title":"Drug targeting to the liver with bile acids: the \u201cTrojan horse\u201d resurrected?","volume":"17","author":"Meijer","year":"1993","journal-title":"Hepatology."},{"key":"10.1016\/j.jinorgbio.2023.112200_bb0080","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0168-8278(99)80046-4","article-title":"Further evidence of the usefulness of bile acids as molecules for shuttling cytostatic drugs toward liver tumors","volume":"31","author":"Monte","year":"1999","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jinorgbio.2023.112200_bb0085","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/ardp.200900075","article-title":"Synthesis and characterization of new liver targeting 5-fluorouracil-cholic acid conjugates","volume":"342","author":"Qian","year":"2009","journal-title":"Arch. Pharm (Weinheim)."},{"key":"10.1016\/j.jinorgbio.2023.112200_bb0090","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/S0022-3565(24)29639-7","article-title":"Low in vivo toxicity of a novel cisplatin-ursodeoxycholic derivative (Bamet-UD2) with enhanced cytostatic activity versus liver tumors","volume":"297","author":"Dominguez","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jinorgbio.2023.112200_bb0095","doi-asserted-by":"crossref","first-page":"540","DOI":"10.2174\/187152008784533008","article-title":"Bile acids and derivatives, their nuclear receptors FXR, PXR and ligands: role in health and disease and their therapeutic potential","volume":"8","author":"Zimber","year":"2008","journal-title":"Anti Cancer Agents Med. Chem."},{"key":"10.1016\/j.jinorgbio.2023.112200_bb0100","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nrgastro.2013.151","article-title":"Bile acid receptors as targets for drug development","volume":"11","author":"Schaap","year":"2014","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jinorgbio.2023.112200_bb0105","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/aps.2011.7","article-title":"Novel liver-specific cholic acid-cytarabine conjugates with potent antitumor activities: synthesis and biological characterization","volume":"32","author":"Chen","year":"2011","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.jinorgbio.2023.112200_bb0110","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/S0022-2275(20)37226-6","article-title":"Synthesis and characterization of a new bile acid and platinum (II) complex with cytostatic activity","volume":"38","author":"Criado","year":"1997","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jinorgbio.2023.112200_bb0115","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0168-8278(98)80315-2","article-title":"Rat liver transport and biotransformation of a cytostatic complex of bis-cholylglycinate and platinum (II)","volume":"28","author":"Marin","year":"1998","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jinorgbio.2023.112200_bb0120","first-page":"3315","article-title":"Relationship between DNA-reactivity and cytostatic effect of two novel bile acid-platinum derivatives, Bamet-UD2 and Bamet-D3","volume":"20","author":"Martinez-Diez","year":"2000","journal-title":"Anticancer Res."},{"key":"10.1016\/j.jinorgbio.2023.112200_bb0125","first-page":"853","article-title":"Carriers involved in targeting the cytostatic bile acid-cisplatin derivatives cis-diammine-chloro-cholylglycinate-platinum (II) and cis-diammine-bisursodeoxycholate-platinum (II) toward liver cells","volume":"61","author":"Briz","year":"2002","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.jinorgbio.2023.112200_bb0130","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.steroids.2019.02.001","article-title":"Synthesis of steroidal 1,2- and 1,3-diamines as ligands for transition metal ion complexation","volume":"147","author":"Seroka","year":"2019","journal-title":"Steroids."},{"key":"10.1016\/j.jinorgbio.2023.112200_bb0135","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0020-1693(00)00095-5","article-title":"Novel spacer linked bile acid-cisplatin compounds as a model for specific drug delivery, synthesis, and characterization","volume":"304","author":"Paschke","year":"2000","journal-title":"Inorg. Chim. Acta"},{"key":"10.1016\/j.jinorgbio.2023.112200_bb0140","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0162-0134(03)00024-2","article-title":"Cholic acid-carboplatin compounds (CarboChAPt) as models for specific drug delivery: synthesis of novel carboplatin analogous derivatives and comparison of the cytotoxic properties with corresponding cisplatin compounds","volume":"94","author":"Paschke","year":"2003","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2023.112200_bb0145","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1021\/bc9901088","article-title":"Structural characterization, kinetic studies, and in vitro biological activity of new cis-diamminebis-cholylglycinate (O, O\u2032) Pt (II) and cis-diamminebis-ursodeoxycholate (O, O\u2032) Pt (II) complexes","volume":"11","author":"Criado","year":"2000","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jinorgbio.2023.112200_bb0150","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1021\/bc970061v","article-title":"Synthesis and characterization of the new cytostatic complex cis-diammineplatinum(II) chlorocholylglycinate","volume":"8","author":"Criado","year":"1997","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jinorgbio.2023.112200_bb0155","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.1021\/acs.chemrev.5b00597","article-title":"The next generation of platinum drugs: targeted Pt(II) agents, nanoparticle delivery, and Pt(IV) prodrugs","volume":"116","author":"Johnstone","year":"2016","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jinorgbio.2023.112200_bb0160","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jconrel.2015.08.022","article-title":"Enhanced antitumour drug delivery to cholangiocarcinoma through the apical sodium-dependent bile acid transporter (ASBT)","volume":"216","author":"Lozano","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jinorgbio.2023.112200_bb0165","doi-asserted-by":"crossref","first-page":"655","DOI":"10.3390\/molecules25030655","article-title":"Synthesis of new cisplatin derivatives from bile acids","volume":"25","author":"Seroka","year":"2020","journal-title":"Molecules."},{"key":"10.1016\/j.jinorgbio.2023.112200_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/742592","article-title":"Synthesis and antiproliferative activity of steroidal thiosemicarbazone platinum (Pt (II)) complexes","volume":"2015","author":"Huang","year":"2015","journal-title":"Bioinorg. Chem. Appl."},{"key":"10.1016\/j.jinorgbio.2023.112200_bb0175","doi-asserted-by":"crossref","first-page":"4611","DOI":"10.1016\/j.bmc.2016.07.066","article-title":"Oleanolic acid-NO donor-platinum (II) trihybrid molecules: targeting cytotoxicity on hepatoma cells with combined action mode and good safety","volume":"24","author":"Fang","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2023.112200_bb0180","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/s41586-020-2569-1","article-title":"Structural basis of GPBAR activation and bile acid recognition","volume":"587","author":"Yang","year":"2020","journal-title":"Nature."},{"key":"10.1016\/j.jinorgbio.2023.112200_bb0185","article-title":"Structural basis of bile acid receptor activation and Gs coupling","volume":"05","author":"Yang","year":"2020","journal-title":"BioRxiv."},{"key":"10.1016\/j.jinorgbio.2023.112200_bb0190","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1002\/ijc.24853","article-title":"Ursodeoxycholic acid switches oxaliplatin-induced necrosis to apoptosis by inhibiting reactive oxygen species production and activating p53-caspase 8 pathway in HepG2 hepatocellular carcinoma","volume":"126","author":"Lim","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jinorgbio.2023.112200_bb0195","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.3390\/12081859","article-title":"Exploitation of bile acid transport systems in prodrug design","volume":"12","author":"Sievanen","year":"2007","journal-title":"Molecules."},{"key":"10.1016\/j.jinorgbio.2023.112200_bb0200","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1002\/cmdc.201300249","article-title":"cis-[Pt(II) (1R,2R-DACH)(3-acetoxy-1,1-cyclobutanedicarboxylato)], a water-soluble, oxalate-free and stable analogue of oxaliplatin: synthesis, characterization, and biological evaluations","volume":"8","author":"Liu","year":"2013","journal-title":"Chem. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2023.112200_bb0205","doi-asserted-by":"crossref","first-page":"4055","DOI":"10.1158\/1078-0432.CCR-03-0666","article-title":"Prevention of oxaliplatin-related neurotoxicity by calcium and magnesium infusions: a retrospective study of 161 patients receiving oxaliplatin combined with 5-fluorouracil and leucovorin for advanced colorectal cancer","volume":"10","author":"Gamelin","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jinorgbio.2023.112200_bb0210","doi-asserted-by":"crossref","first-page":"6359","DOI":"10.1158\/1078-0432.CCR-07-0660","article-title":"Predictive factors of oxaliplatin neurotoxicity: the involvement of the oxalate outcome pathway","volume":"13","author":"Gamelin","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jinorgbio.2023.112200_bb0215","doi-asserted-by":"crossref","first-page":"4470","DOI":"10.1021\/cr4004314","article-title":"Synthetic methods for the preparation of platinum anticancer complexes","volume":"114","author":"Wilson","year":"2014","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jinorgbio.2023.112200_bb0220","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1002\/hep.26007","article-title":"Hepatic transforming growth factor beta gives rise to tumor-initiating cells and promotes liver cancer development","volume":"56","author":"Wu","year":"2012","journal-title":"Hepatology."},{"key":"10.1016\/j.jinorgbio.2023.112200_bb0225","doi-asserted-by":"crossref","first-page":"5324","DOI":"10.1021\/ic200436u","article-title":"A novel water-soluble heptaplatin analogue with improved antitumor activity and reduced toxicity","volume":"50","author":"Liu","year":"2011","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2023.112200_bb0230","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1595\/147106712X654204","article-title":"3-Hydroxy-carboplatin, a simple carboplatin derivative endowed with an improved toxicological profile","volume":"56","author":"Liu","year":"2012","journal-title":"Platin. Met. Rev."},{"key":"10.1016\/j.jinorgbio.2023.112200_bb0235","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.ejmech.2007.09.006","article-title":"Synthesis and anticancer activity of lipophilic platinum(II) complexes of 3,5-diisopropyl salicylate","volume":"43","author":"Yu","year":"2008","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2023.112200_bb0240","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3109\/01480545.2010.500292","article-title":"Systemic toxicity and toxicokinetics of a high dose of polyethylene glycol 400 in dogs following intravenous injection","volume":"34","author":"Li","year":"2011","journal-title":"Drug Chem. Toxicol."},{"issue":"12","key":"10.1016\/j.jinorgbio.2023.112200_bb0245","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115028","article-title":"Hepatic farnesoid Xreceptor isoforms \u03b12 and \u03b14 differentially modulate bile salt and lipoprotein metabolism in mice","volume":"9","author":"Boesjes","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jinorgbio.2023.112200_bb0250","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1002\/hep.26187","article-title":"Bile salt export pump ss dysregulated with altered Farnesoid X receptor isoform expression in patients with hepatocellular carcinoma","volume":"57","author":"Chen","year":"2013","journal-title":"Hepatology."},{"key":"10.1016\/j.jinorgbio.2023.112200_bb0255","article-title":"Role of farnesoid X receptor in the pathogenesis of respiratory diseases","volume":"2020","author":"Wu","year":"2020","journal-title":"Can. Respir. J."}],"container-title":["Journal of Inorganic Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016201342300082X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016201342300082X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T15:09:36Z","timestamp":1758985776000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016201342300082X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":51,"alternative-id":["S016201342300082X"],"URL":"https:\/\/doi.org\/10.1016\/j.jinorgbio.2023.112200","relation":{},"ISSN":["0162-0134"],"issn-type":[{"value":"0162-0134","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and biological evaluation of cholic acid-conjugated oxaliplatin as a new prodrug for liver cancer","name":"articletitle","label":"Article Title"},{"value":"Journal of Inorganic Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinorgbio.2023.112200","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"112200"}}